Solta Fraxel re:fine
Non-Ablative Fractional · 1410nm fractional
What it's actually cleared for: 1410nm non-ablative fractional resurfacing (Fraxel SR family)
Last verified: August 6, 2026 · How we verify
New: —|Used: $5k–$12kmarket estimate, no email required
Overview
Entry Fraxel, short-lived
FDA & regulatory status
What it's actually cleared for:
1410nm non-ablative fractional resurfacing (Fraxel SR family)
510(k) numbers
K050841; K062303; K063038
Regulatory data is compiled from public FDA 510(k) records and may lag recent clearances. Always confirm status with the manufacturer before purchase.
Treatment economics
Economics data for this platform hasn't been published yet.
Chains using this device
No confirmed chain deployments recorded yet.
Owner reviews
Write a reviewNo approved reviews yet. Be the first owner to publish one.
Alternatives
History
Every tracked change to pricing, lifecycle status, FDA data and warranty terms — newest first.
August 5, 2026
FDA status
Unknown → Cleared
Source: Automatic record update
August 5, 2026
FDA K-numbers
K050841; K062303; K063038
Source: Automatic record update
August 5, 2026
FDA indication
1410nm non-ablative fractional resurfacing (Fraxel SR family)
Source: Automatic record update
August 1, 2026
Record created
Added to The Aesthetic Index — August 2026
Source: The Aesthetic Index editorial
Get the full State of Aesthetic Devices 2026 report
The first independent census of the US aesthetic device market — free.